FORGOTTEN HISTORY: Organon - Caught on Camera

Sun Pharma books Rs 346 crore Organon deal costs in Q2; profit falls 36%

Sun Pharmaceutical Industries experienced a significant decline in net profit during the September quarter of FY27. The company incurred acquisition-related costs of Rs 346.16 crore while preparing for the Organon acquisition. Revenue from operations increased by 11.9% compared to the same quarter last year. An important settlement of Rs 922.67…

The Economic Times · Oct 30

Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges

Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.

The Economic Times · Oct 30

Sun Pharma plans $1 billion local debt sale for loan takeout, sources say

Sun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organon acquisition, according to Reuters. The drugmaker is expected to issue two-, three- and four-year bonds as Indian companies increasingly turn to domestic debt amid high US borrowing…

The Economic Times · Sep 29

S&P 500, Nasdaq Nab Best Weeks Since November: Stock Market Today

Strong gains in mega-cap tech stocks buoyed the Nasdaq on Friday, but the Dow and S&P 500 weren't so resilient.

Kiplinger · Apr 10

Organon Cuts 2025 Sales Outlook Despite Earnings Beat

Organon (NYSE:OGN) reported third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus estimate of 94 cents. The global healthcare company reported quarterly sales of $1.602 billion, beating the Wall Street estimate of $1.56 billion.

Benzinga · Nov 10, 2025

5 Stocks to Buy for a Harris Presidency

The race for the White House is heating up and these five stocks are set to benefit if Kamala Harris claims victory.

Kiplinger · Sep 14, 2024

If companies don't train Gen Zers, they'll train themselves

Gen Z is having a hard time getting entry-level jobs, plus companies are hiring fewer interns.

Fortune · Aug 28, 2024

3 Cheap Small-Cap Stocks to Scoop Up on the Market Pullback

With small-cap stocks grabbing investors' attention lately, here are three discounted names with solid fundamentals to grab now, while the retracement provides a prime entry point.

Barchart · Aug 2, 2024

3 Healthcare Stocks With The Highest Yields As of June 2024

Looking for yield? Here's 3 healthcare stocks with the highest yields today.

Barchart · Jun 12, 2024

Warning over asthma drug after 500 neuropsychiatric reactions reported in young children

UK medicines regulator says information accompanying montelukast will alert users to risk of mood and behaviour changes

The Guardian - UK · May 4, 2024